OpenAlex
PricingAboutJobs
Log inGet started
Work

A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.

PubMed

Year: 2001
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: G I Shapiro, J G Supko, A Patterson, C Lynch, J Lucca, P F Zacarola, A Muzikansky, J J Wright, T J Lynch, B J Rollins
Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: flavopiridol, cyclin-dependent kinase inhibitors, non-small cell lung cancer, treatment-naive patients, continuous infusion, steady-state plasma concentration, drug toxicity, diarrhea, venous thrombosis, disease stability, early stopping rules
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
OpenAlex ID: W2170302386
FWCI: 12.66
Cites: 58
Cited by: 193
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms